Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Traditional Chinese Medicines Seen As Global Growth Opportunity

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Health authorities around the world are working to develop regulatory structures for traditional Chinese medicines

You may also be interested in...

India Plans Facelift For Traditional Medicine With Separate Drug Regulator

Having taken an image beating on quality concerns, India’s traditional Ayurveda medicine is getting new attention in a major government initiative.

When East Meets West, Global Cancer Research Improves – China Health Minister

Wearing two hats as a hematologist and China’s health minister, Zhu Chen says basic research and policymaking are interrelated and mutually beneficial.

After Tough 2011 For Chinese Healthcare IPOs, Policy And Cost Relief Could Be On The Way

China's pharma IPOs didn't meet the hype in 2011. Government action may now ease speculation mania.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts